- Research article
- Open Access
- Open Peer Review
The use of PCR/Electrospray Ionization-Time-of-Flight-Mass Spectrometry (PCR/ESI-TOF-MS) to detect bacterial and fungal colonization in healthy military service members
BMC Infectious Diseasesvolume 16, Article number: 338 (2016)
The role of microbial colonization in disease is complex. Novel molecular tools to detect colonization offer theoretical improvements over traditional methods. We evaluated PCR/Electrospray Ionization-Time-of-Flight-Mass Spectrometry (PCR/ESI-TOF-MS) as a screening tool to study colonization of healthy military service members.
We assessed 101 healthy Soldiers using PCR/ESI-TOF-MS on nares, oropharynx, and groin specimens for the presence of gram-positive and gram-negative bacteria (GNB), fungi, and antibiotic resistance genes. A second set of swabs was processed by traditional culture, followed by identification using the BD Phoenix automated system; comparison between PCR/ESI-TOF-MS and culture was carried out only for GNB.
Using PCR/ESI-TOF-MS, at least one colonizing organism was found on each individual: mean (SD) number of organisms per subject of 11.8(2.8). The mean number of organisms in the nares, groin and oropharynx was 3.8(1.3), 3.8(1.4) and 4.2(2), respectively. The most commonly detected organisms were aerobic gram-positive bacteria: primarily coagulase-negative Staphylococcus (101 subjects: 341 organisms), Streptococcus pneumoniae (54 subjects: 57 organisms), Staphylococcus aureus (58 subjects: 80 organisms) and Nocardia asteroides (45 subjects: 50 organisms). The mecA gene was found in 96 subjects. The most commonly found GNB was Haemophilus influenzae (20 subjects: 21 organisms) and the most common anaerobe was Propionibacterium acnes (59 subjects). Saccharomyces species (30 subjects) were the most common fungi detected. Only one GNB (nares E. coli) was identified in the same subject by both diagnostic systems.
PCR/ESI-TOF-MS detected common colonizing organisms and identified more typically-virulent bacteria in asymptomatic, healthy adults. PCR/ESI-TOF-MS appears to be a useful method for detecting bacterial and fungal organisms, but further clinical correlation and validation studies are needed.
Our understanding of the nature of host-microbe interactions has become increasingly complex, with the line between pathogen and non-pathogen becoming more and more obscure . Individual organism and human factors, in addition to complex interactions between host and pathogen, play significant roles in determining the colonization-infection-disease spectrum [1–6]. Historically, the role of the human microbiome in disease has been poorly understood, partly due to limitations of standard microbiological culture [6–8]. Recently, novel molecular platforms such as PCR/Electrospray Ionization-Time-of-Flight-Mass Spectrometry (PCR/ESI-TOF-MS) have shown potential benefits over standard microbiological culture, including increased throughput and cost savings . PCR/ESI-TOF-MS offers not only microbiologic organism identification, but the capability to detect genetic resistance elements. This molecular tool has also shown high concordance with traditional culture methods in identifying microorganisms in blood cultures  and in different orthopedic populations [11, 12]. There have been only a few studies using PCR/ESI-TOF-MS to explore colonization rates, with some published surveillance studies from a burn intensive care unit and orthopedic ward healthcare workers, and preliminary data on staphylococcal colonization in United States military personnel [13, 14]. Given the potential link between colonization and modification of the microbiome to subsequent infections, this pilot study sought to examine bacterial and fungal colonization of healthy individuals using PCR/ESI-TOF-MS, to further understand human microbiome diversity using a newer molecular platform, and to compare gram-negative bacteria (GNB) detection by PCR/ESI-TOF-MS with traditional culture.
One hundred one healthy active duty service members presenting to the outpatient Troop Medical Clinic for acute care at Fort Sam Houston, TX were enrolled. Study participants were 18 years and older who had no overseas travel or deployment within the past 6 months, no antibiotic use in the preceding 30 days, and were being seen for non-infectious medical conditions. Written informed consent was obtained from study participants upon enrollment. Individuals were excluded from the study if they were deemed to have an acute or chronic infection that may have altered normal bacterial flora or that involved a proposed anatomic sample site. The study protocol was approved by the San Antonio Military Medical Center (SAMMC) Institutional Review Board. The results presented here are a sub-study of a larger protocol examining various methods for detecting microbial colonization in healthy US military personnel; initial results on methicillin-resistant and methicillin-sensitive Staphylococcus aureus (MRSA and MSSA) and multidrug-resistant (MDR) GNB colonization have been published [14, 15]. Our current study further examines bacterial and fungal colonization of healthy U.S. military individuals, including the correlation of GNB detection by PCR/ESI-TOF-MS and traditional culture.
Specimen collection and processing
Individuals were screened with culture swabs (Copan Stuart liquid media culture, Copan Inc., Brescia, Italy) from various anatomic sites (nares, oropharynx, and groin). Each participant was sampled by application of the swab in a repetitive twisting motion at each anatomic site, firmly brushing the skin or mucosa to ensure transfer of cells onto the swab tip. Samples for PCR/ESI-TOF-MS were frozen at -20o C or lower and transported on dry ice for batched testing to the Center for Genomic Sciences, Allegheny Singer Research Institute, Pittsburgh, PA, USA. A separate set of swabs collected in the same fashion were transported to the SAMMC research microbiology laboratory and underwent immediate processing for microbial culture to identify GNB. The analysis of coagulase-negative Staphylococcus (CNS) and S. aureus detection by traditional culture and PCR/ESI-TOF-MS methods has been published elsewhere . We did not evaluate other gram-positive bacteria, fungus or anaerobes by traditional culture due to cost constraints.
Frozen swabs were thawed after transport, placed in microcentrifuge tubes containing 270 μl of ATL Lysis buffer (Qiagen, Germantown, MD, cat# 19076) and 30 μl proteinase K (Qiagen, cat# 19131) and then incubated at 56 °C for 1 h. Next, 100 μl of a mixture containing 50 μl each of 0.1 mm and 0.7 mm Zirconia beads (Biospec, Bartlesville, OKcat# 11079101z, 11079107zx, respectively) were added to the samples which were then homogenized for 10 min at 25 Hz using a Qiagen Tissuelyser. Nucleic acid from the lysed sample was then extracted using the Qiagen DNeasy kit (Qiagen cat# 69506). 10 μl of each sample was loaded per well onto the BAC detection PCR plate (Abbott Molecular, Carlsbad, CA cat# PN 05 N13-01). The BAC detection plate contains 96 wells each with 16 primers that survey all bacterial organisms by using multiple omnipresent loci (e.g., 16S rDNA sequences) and multiple pluripresent loci (e.g., the tufB gene). The BAC assay has been validated against 613 organisms . The system also detects the presence of several key antibiotic resistance markers: vanA and vanB (vancomycin resistance) in Enterococcus spp., KPC-3 (carbapenem resistance) in GNB, and mecA (methicillin resistance) in Staphylococcus spp. An internal calibrant of synthetic nucleic acid template is also included in each assay, controlling for false negatives (e.g., from PCR inhibitors) and enabling a semi-quantitative analysis of the amount of template DNA present. PCR amplification was performed according to Ecker et al.  The PCR products were then desalted in a 96-well plate format and sequentially electrosprayed into a time-of-flight mass spectrometer. The spectral signals were processed to determine the masses of each of the PCR products present with sufficient accuracy to determine the base composition of each amplicon. Using combined base compositions from multiple PCRs, the identities of the pathogens and a semi-quantitative determination of their relative concentrations in the starting sample were established by using a proprietary algorithm which interfaces with the Ibis database of known organisms.
All isolates were plated onto both Trypticase™ Soy Agar with 5 % sheep blood (sheep blood agar, BBL, Cockeysville, MD, USA) and MacConkey agar (BBL, Cockeysville, MD, USA) in order to isolate aerobic GNB colonies. Colonies grown on MacConkey agar and colonies consistent with gram-negative morphology on sheep blood agar were sub-cultured onto sheep blood agar to assure culture purity and then frozen at -80o C for subsequent evaluation. Frozen isolates underwent two passages on sheep blood agar, followed by automated testing for species-identification and susceptibility via the BD Phoenix Automated Microbiology System (Becton Dickinson and Company, Franklin Lakes, NJ) using NMIC/ID-123 panels according to manufacturer’s guidelines.
Organisms were categorized based on taxonomy and morphological features. Basic descriptive statistics were used to summarize the findings using SPSS (IBM®SPSS®Statistics Version 19). Comparison between PCR/ESI-TOF-MS and traditional culture results was only performed on GNB utilizing Spearman’s rank correlation.
Three anatomic sites (nares, oropharynx, and groin) of 101 participants were swabbed, with one subject declining the oropharynx swab. The median age of participants was 23 [IQR 22, 23] years, with 69 % being male.
PCR/ESI-TOF-MS identified at least one organism in every subject, with a mean number of 11.8 [SD 2.8] organisms per subject. The most commonly deteceted gram positive and gram negative bacteria, by anatomic site, are shown in Figs. 1 and 2. The oropharynx site yielded the highest mean number of organisms, 4.2 [SD 2.0] followed by groin 3.8 [SD 1.4] and nares 3.8 [SD 1.3] (Table 1).
Overall, aerobic gram-positive bacteria were more prevalent than GNB (870 vs. 140 total isolates, respectively) and were detected from every subject, with a mean number of 8.6 [SD 2.0] organisms, the highest number being detected from groin swabs, 3.3 [SD 3.3] followed by nares 2.7 [SD 1.3] and oropharynx 2.6 [SD 1.3] (Table 1). PCR/ESI-TOF-MS identified 870 aerobic gram-positive bacteria (329 from groin swabs, 275 from nares, and 266 from oropharynx). The most common organisms (341) were CNS with numerous other gram-positive bacteria noted (Table 2). The mecA gene was identified in nearly every subject (96). No resistance elements of vanA and vanB were detected in this study.
Aerobic GNB were also commonly found by PCR/ESI-TOF-MS in 80 subjects, with a mean number of 1.4 [SD 1.0] organisms, primarily the oropharynx followed by nares and groin (Table 1). In total, 140 aerobic GNB were identified (94 from oropharynx swabs, 32 from nares, and 14 from groin). The most common GNB identified were Neisseria spp. (59), followed by Haemophilus influenzae (21), Moraxella spp. (19), and Escherichia coli (7) (Table 3). As was seen with gram-positive bacteria, several GNB known to cause human disease were frequently found (Table 3). No genes commonly associated with GNB resistance were detected by PCR/ESI-TOF-MS.
Multiple anaerobic bacteria were detected by PCR/ESI-TOF-MS in 75 subjects, with a mean number of 1.2 [SD 0.98] organisms; the most common site being the nares (56 subjects – mean number of 0.6 [SD 0.6] organisms) (Table 1). In total, 96 anaerobic gram-positive bacteria (6 from oropharynx swabs, 57 from nares, and 33 from groin) and 27 anaerobic GNB were identified (23 from oropharynx swabs, 3 from nares, and 1 from groin). Propionibacterium acnes was the most commonly identified anaerobic gram-positive bacteria (70) (Table 4).
PCR/ESI-TOF-MS identified fungal species in 46 subjects with a mean of 0.60 [SD 0.79] organisms per individual (Table 1). A total of 61 fungal organisms, with 39 in the oropharynx, 14 nares, and 8 groin were detected (Table 5).
PCR/ESI-TOF-MS compared with traditional culture for gram-negative bacteria
Traditional culture identified colonization of 34 sites from 23 subjects with GNB. The most commonly recovered organism was Pseudomonas aeruginosa with 4 isolates, all of which were from oropharyngeal sites. Other GNB included E.coli (3 isolates), K. pneumoniae (3 isolates), and Serratia marcescens (3 isolates). A complete list of less common GNB is shown in Table 6. Traditional culture also did not detect any MDR GNB.
PCR/ESI-TOF-MS found more GNB isolates than traditional culture (80 subjects versus 23 subjects). When comparing the organisms found by PCR/ESI-TOF-MS and traditional culture, only one non-MDR E. coli was identified by both systems from the same subject and collection site (nares). Similarly, neither method detected any MDR GNB. Spearman correlation between GNB on traditional culture versus PCR/ESI-TOF-MS for nares was 0.68, oropharynx was 0.44, and groin was 0.13.
Pathogen detection has several limitations within the current practices of traditional microbiological methods. Newer molecular diagnostic methods, such as PCR/ESI-TOF-MS, offer potential advantages over traditional microbiological methods in detecting microbial pathogens. One potential limitation of traditional microbiology is the inability to culture specific organisms in the laboratory due to difficulty in replicating the perfect media for growth while molecular platforms, such as PCR/ESI-TOF-MS, circumvent this by focusing on the genetic elements present in a sample for organism identification. In this study, PCR/ESI-TOF-MS detected many clinically relevant bacteria (e.g., Neisseria meningitidis, N. gonorrhoeae, N. asteroides, S. pneumoniae, Fusobacterium necrophorum) that are typically associated with virulent infections in a population without evidence of clinical disease, and identified multiple isolates of more fastidious organisms such as N. asteroides and several nutritionally deficient Streptococcus spp.
PCR/ESI-TOF-MS detected large numbers of isolates of expected commensal organisms, especially among the aerobic gram-positive bacteria, with CNS being most commonly identified. The carriage rate of S. pneumoniae using standard microbiological methods has previously been reported in adult populations, varying in reported prevalence from 3.7 to 38 % [16, 17]. Among a healthy, primarily young adult population in this study, the S. pneumoniae carriage rate was found to be 53.5 %. This is significantly higher than previously reported and is similar to carriage rates previously shown in young children populations (53–67 %) [16, 17] S. aureus was also commonly found in 57.4 % of individuals sampled in this study, consistent with previously reported colonization rates between 32.7 and 53 % [18–23] Streptococcus agalactiae was found on 26.7 % of subjects in this study. While S. agalactiae has been evaluated previously in vaginal and anorectal colonization studies; there have been limited colonization studies looking at carriage rates in other anatomic sites. The reported colonization rate has varied from 8.5 to 32.9 % depending on the study population and geographic location [24–28].
In addition to colonization with expected organisms, PCR/ESI-TOF-MS also detected traditionally pathologic aerobic gram-positive bacteria such as N. asteroides in a high percentage of the study population in absence of clinical disease. N. asteroides, which traditionally has not been thought of as part of the body’s normal flora , was detected in 44.5 % of the study population, most commonly from the nares (30 isolates) and groin (19 isolates). While this is surprisingly high, Nocardia has been difficult to grow and identify by traditional culture historically and, for this reason, other direct molecular detection methods have been evaluated for enhanced identification of Nocardia [30, 31]. Case series have previously shown Nocardia colonization of the respiratory tract without clinical or radiographic findings consistent with disease, however all these patients had underlying lung disease [32, 33].
PCR/ESI-TOF-MS also found a small number of Streptococcus species, formerly known as nutritionally deficient Streptococci, such as Granulicatella adiacens, G. sanguinis, Abiotrophia defectiva, Gemella haemolysans, A. elegans which, similar to N. asteroides, are difficult to isolate but associated with disease including endocarditis. Although infrequently studied, Abiotrophia, Granulicatella, and Gemella have been shown, using molecular methods, to account for a significant part of the human oral microbiome [7, 34].
Genetic resistance elements common to gram-positive bacteria were also examined, and the mecA gene was found in nearly every subject (96/101 subjects). Staphylococcus resistance was felt to be a broader study question comparing PCR/ESI-TOF-MS with detection by traditional culture, and has been previously published; therefore, the data are not presented in this manuscript . Other specific genetic markers of resistance, such as the vanA and vanB genes, were not identified in our study isolates. The significance of these resistance markers in terms of clinical diagnosis and therapy is unclear. Clinical decision making regarding decolonization might be affected by the presence of genetic resistance elements, particularly if they are transferred between pathogens co-located on the body.
Aerobic GNB findings were similar to those of gram-positive bacteria, such as PCR/ESI-TOF-MS detected large numbers of expected colonizing organisms (e.g., H. influenzae and Moraxella catarrhalis), with fewer numbers of organisms associated with clinical virulence in healthy individuals. In this study of healthy military personnel, the H. influenzae carriage rate was determined to be 19.8 % and the M. catarrhalis carriage rate was 8.9 %. In a previous carriage study of H. influenzae and M. catarrhalis in healthy, asymptomatic individuals, adult carriage rates were 23 and 17 %, respectively . PCR/ESI-TOF-MS also identified important GNB human pathogens such as Burkholderia cenocepacia, N. gonorrhoeae, N. meningitides, and Rickettsia sp. which again are not thought of as traditional colonizing organisms. No genetic resistance elements for GNB were found in this study.
While PCR/ESI-TOF-MS did identify some unexpected GNB, it identified only a few Acinetobacter spp. (3 subjects) and no P. aeruginosa, which are two examples of potential MDR organisms. There are limited numbers of studies using similar populations, however a study looking at surveillance of organisms in a burn intensive care unit and orthopedic ward found a higher prevalence of Acinetobacter and P. aeruginosa . While outpatient colonization rates of A. baumannii-calcoaceticus (ABC) have been variable, U.S. Army soldiers without significant healthcare exposure have been shown to have lower carriage rates, whereas hospitalized soldiers have much higher rates of colonization [15, 35–38].
Similar to aerobic bacteria, anaerobic bacteria and fungi known to be members of the colonizing human microbiota were found with PCR/ESI-TOF-MS. P. acnes was the most commonly detected anaerobic gram-positive bacteria, Bacteroides spp. the most common anaerobic GNB, and Saccharomyces cerevisiae/paradoxus the most common fungus. Notably, Fusobacterium spp., commonly thought to be pathogenic organisms, were isolated in 8 asymptomatic, healthy subjects.
A limitation of PCR/ESI-TOF-MS in this study, that may warrant further evaluation prior to broader application, was the limited anatomic site-correlation between screening methods. Only one pathogen was identified by both systems in the same subject from the same anatomic site (E.coli from the nares). This discordance has been observed elsewhere, with one study reporting a relatively high false negative rate with PCR/ESI-MS when trying to resolve mixtures . There are several potential reasons for this discordance. With molecular platforms, such as PCR/ESI-TOF-MS, there is a greater uncertainty as to what is being sampled. Some investigators have suggested a role for preferential amplification, where the DNA primers are saturated from the most abundant organisms present, causing organisms in smaller quantity to be missed . Another limitation is that we did not screen for all gram-positive bacteria, fungi, or anaerobes with traditional culture for comparison. In addition, this pilot study also evaluated only a limited number of anatomic sites per individual, which may have led to an underestimate of the total number and diversity of potential isolates from our study participants – in fact microbiome studies have identified a high degree of heterogeneity among nearly all anatomic sites. The lack of additional confirmatory tests (e.g., a second molecular diagnostic platform) to validate the PCR/ESI-TOF-MS findings is also a potential study limitation. Furthermore, a limited number of subjects were examined in one particular environment and study participants were only screened at a single time point, limiting our ability to determine if individuals were only transiently colonized. Future studies evaluating individuals over a period of time would be helpful in determining the incidence and prevalence of true colonization. Validation of this molecular method as a colonization screening tool for a broad array of pathogens might be particularly useful for patients at higher risk for infection, such as immunosuppressed or burn patients.
In summary, the PCR/ESI-TOF-MS detected large numbers of isolates of expected commensal organisms in a population of healthy, asymptomatic individuals, but it also detected many bacteria (e.g., N. meningitidis, N. gonorrhoeae, N. asteroides, S. pneumoniae, Fusobacterium spp.) that are often associated with clinically virulent infections suggesting that presence alone does not trigger virulence . This molecular platform identified higher carriage percentages for pathogenic bacteria than have been previously shown in the literature, and identified multiple organisms that have traditionally been difficult to culture in the laboratory. Additional advantages of this molecular platform are the potential for increased sample throughput with decreased processing times. Further validation with confirmatory molecular technologies should be performed to ascertain the clinical significance of identified organisms and appropriate clinical application.
GNB, gram negative bacteria; MRSA, methicillin-resistant Staphylococcus aureus; MSSA, methicillin-susceptible Staphylococcus aureus; PCR/ESI-TOF-MS, polymerase chain reaction/electrospray ionization-time-of-flight-mass spectrometry
Ehrlich GD, Hiller NL, Hu FZ. What makes Pathogens Pathogenic. Genome Biol. 2008;9(6):225.
Casadevall A, Pirofski LA. Host-pathogen interactions: redefining the basic concepts of virulence and pathogenicity. Infect Immun. 1999;67(8):3703–13.
Casadevall A, Pirofski LA. Host-pathogen interactions: basic concepts of microbial commensalism, colonization, infection, and disease. Infect Immun. 2000;68(12):6511–8.
Johannessen M, Sollid JE, Hanssen AM. Host- and microbe determinants that may influence the success of S. aureus colonization. Frontiers in Cellular and Infection Microbiology. 2012;2:56.
Kadioglu A, Weiser JN, Paton JC, Andrew PW. The role of Streptococcus pneumoniae virulence factors in host respiratory colonization and disease. Nat Rev Micro. 2008;6(4):288–301.
Peacock SJ, de Silva I, Lowy FD. What determines nasal carriage of Staphylococcus aureus? Trends Microbiol. 2001;9(12):605–10.
Dewhirst FE, Chen T, Izard J, Paster BJ, Tanner AC, Yu WH, Lakshmanan A, Wade WG. The human oral microbiome. J Bacteriol. 2010;192(19):5002–17.
Wade WG. Has the use of molecular methods for the characterization of the human oral microbiome changed our understanding of the role of bacteria in the pathogenesis of periodontal disease? J Clin Periodontol. 2011;38 Suppl 11:7–16.
Ecker DJ, Sampath R, Massire C, Blyn LB, Hall TA, Eshoo MW, Hofstadler SA. Ibis T5000: a universal biosensor approach for microbiology. Nat Rev Micro. 2008;6(7):553–8.
Laffler TG, Cummins LL, McClain CM, Quinn CD, Toro MA, Carolan HE, Toleno DM, Rounds MA, Eshoo MW, Stratton CW, Sampath R, Blyn LB, Ecker DJ, Tang YW. Enhanced diagnostic yields of bacteremia and candidemia in blood specimens by PCR-electrospray ionization mass spectrometry. J Clin Microbiol. 2013;51(11):3535–41.
Greenwood-Quaintance KE, Uhl JR, Hanssen AD, Sampath R, Mandrekar JN, Patel R. Diagnosis of prosthetic joint infection by use of PCR-electrospray ionization mass spectrometry. J Clin Microbiol. 2014;52(2):642–9.
Jacovides CL, Kreft R, Adeli B, Hozack B, Ehrlich GD, Parvizi J. Successful identification of pathogens by polymerase chain reaction (PCR)-based electrospray ionization time-of-flight mass spectrometry (ESI-TOF-MS) in culture-negative periprosthetic joint infection. J Bone Joint Surg Am. 2012;94(24):2247–54.
Yun HC, Kreft RE, Castillo MA, Ehrlich GD, Guymon CH, Crouch HK, Chung KK, Wenke JC, Hsu JR, Spirk TL, Costerton JW, Mende K, Murray CK. Comparison of PCR/electrospray ionization-time-of-flight-mass spectrometry versus traditional clinical microbiology for active surveillance of organisms contaminating high-use surfaces in a burn intensive care unit, an orthopedic ward and healthcare workers. BMC Infect Dis. 2012;12:252.
Shaw AG, Vento TJ, Mende K, Kreft RE, Ehrlich GD, Wenke JC, Spirk T, Landrum ML, Zera W, Cheatle KA, Guymon C, Calvano TP, Rini EA, Tully CC, Beckius ML, Murray CK. Detection of methicillin-resistant and methicillin-susceptible Staphylococcus aureus colonization of healthy military personnel by traditional culture, PCR, and mass spectrometry. Scand J Infect Dis. 2013;45(10):752–9.
Vento TJ, Cole DW, Mende K, Calvano TP, Rini EA, Tully CC, Zera WC, Guymon CH, Yu X, Cheatle KA, Akers KS, Beckius ML, Landrum ML, Murray CK. Multidrug-resistant gram-negative bacteria colonization of healthy US military personnel in the US and Afghanistan. BMC Infect Dis. 2013;13:68.
Mackenzie GA, Leach AJ, Carapetis JR, Fisher J, Morris PS. Epidemiology of nasopharyngeal carriage of respiratory bacterial pathogens in children and adults: cross-sectional surveys in a population with high rates of pneumococcal disease. BMC Infect Dis. 2010;10:304.
Regev-Yochay G, Raz M, Dagan R, Porat N, Shainberg B, Pinco E, Keller N, Rubinstein E. Nasopharyngeal carriage of Streptococcus pneumoniae by adults and children in community and family settings. Clin Infect Dis. 2004;38(5):632–9.
Frank DN, Feazel LM, Bessesen MT, Price CS, Janoff EN, Pace NR. The human nasal microbiota and Staphylococcus aureus carriage. PLoS One. 2010;5(5):e10598.
Lederer SR, Riedelsdorf G, Schiffl H. Nasal carriage of meticillin resistant Staphylococcus aureus: the prevalence, patients at risk and the effect of elimination on outcomes among outclinic haemodialysis patients. Eur J Med Res. 2007;12(7):284–8.
Pires FV, da Cunha ML, Abraao LM, Martins PY, Camargo CH, Fortaleza CM. Nasal Carriage of Staphylococcus aureus in Botucatu Brazil: A Population-Based Survey. PLoS One. 2014;9(3):e92537.
Kluytmans J, van Belkum A, Verbrugh H. Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks. Clin Microbiol Rev. 1997;10(3):505–20.
Cursino MA, Garcia CP, Lobo RD, Salomao MC, Gobara S, Raymundo GF, Kespers T, Soares RE, Mollaco CH, Keil KG, Malieno PB, Krebs VL, Gibelli MA, Kondo MM, Zugaib M, Costa SF, Levin AS. Performance of surveillance cultures at different body sites to identify asymptomatic Staphylococcus aureus carriers. Diagn Microbiol Infect Dis. 2012;74(4):343–8.
Kenner J, O'Connor T, Piantanida N, Fishbain J, Eberly B, Viscount H, Uyehara C, Hospenthal D. Rates of carriage of methicillin-resistant and methicillin-susceptible Staphylococcus aureus in an outpatient population. Infect Control Hosp Epidemiol. 2003;24(6):439–44.
Orrett FA. Colonization with Group B streptococci in pregnancy and outcome of infected neonates in Trinidad. Pediatr Int. 2003;45(3):319–23.
El Aila NA, Tency I, Claeys G, Saerens B, Cools P, Verstraelen H, Temmerman M, Verhelst R, Vaneechoutte M. Comparison of different sampling techniques and of different culture methods for detection of group B streptococcus carriage in pregnant women. BMC Infect Dis. 2010;10:285.
El-Kersh TA, Al-Nuaim LA, Kharfy TA, Al-Shammary FJ, Al-Saleh SS, Al-Zamel FA. Detection of genital colonization of group B streptococci during late pregnancy. Saudi Med J. 2002;23(1):56–61.
Al-Sweih N, Maiyegun S, Diejomaoh M, Rotimi V, Khodakhast F, Hassan N, George S, Baig S. Streptococcus agalactiae (Group B Streptococci) carriage in late pregnancy in Kuwait. Med Princ Pract. 2004;13(1):10–4.
Chaudhry BY, Akhtar N, Balouch AH. Vaginal carriage rate of group B Streptococcus in pregnant women and its transmission to neonates. J Ayub Med Coll Abbottabad. 2010;22(4):167–70.
Lerner PI. Nocardiosis. Clin Infect Dis. 1996;22(6):891–903. quiz 4–5.
Couble A, Rodriguez-Nava V, de Montclos MP, Boiron P, Laurent F. Direct detection of Nocardia spp. in clinical samples by a rapid molecular method. J Clin Microbiol. 2005;43(4):1921–4.
Alfaresi M, Elkosh A. Rapid identification of clinically relevant Nocardia species using real-time PCR with SYBR Green and melting-curve analysis. J Med Microbiol. 2006;55(Pt 12):1711–5.
Minero MV, Marin M, Cercenado E, Rabadan PM, Bouza E, Munoz P. Nocardiosis at the turn of the century. Medicine. 2009;88(4):250–61.
Saubolle MA, Sussland D. Nocardiosis: review of clinical and laboratory experience. J Clin Microbiol. 2003;41(10):4497–501.
Jorgensen JH. Need for susceptibility testing guidelines for fastidious or less-frequently isolated bacteria. J Clin Microbiol. 2004;42(2):493–6.
Griffith ME, Ceremuga JM, Ellis MW, Guymon CH, Hospenthal DR, Murray CK. Acinetobacter skin colonization of US Army Soldiers. Infect Control Hosp Epidemiol. 2006;27(7):659–61.
Weintrob AC, Murray CK, Lloyd B, Li P, Lu D, Miao Z, Aggarwal D, Carson ML, Gaskins LJ, Tribble DR. Active surveillance for asymptomatic colonization with multidrug-resistant Gram-negative bacilli among injured service members--a three year evaluation. MSMR. 2013;20(8):17–22.
Kaspar RL, Griffith ME, Mann PB, Lehman DJ, Conger NG, Hospenthal DR, Murray CK. Association of bacterial colonization at the time of presentation to a combat support hospital in a combat zone with subsequent 30-day colonization or infection. Mil Med. 2009;174(9):899–903.
Scott P, Deye G, Srinivasan A, Murray C, Moran K, Hulten E, Fishbain J, Craft D, Riddell S, Lindler L, Mancuso J, Milstrey E. Bautista CT, Patel J, Ewell A, Hamilton T, Gaddy C, Tenney M, Christopher G, Petersen K, Endy T, Petruccelli B. An outbreak of multidrug-resistant Acinetobacter baumannii-calcoaceticus complex infection in the US military health care system associated with military operations in Iraq. Clin Infect Dis. 2007;44(12):1577–84.
Kaleta EJ, Clark AE, Johnson DR, Gamage DC, Wysocki VH, Cherkaoui A, Schrenzel J, Wolk DM. Use of PCR coupled with electrospray ionization mass spectrometry for rapid identification of bacterial and yeast bloodstream pathogens from blood culture bottles. J Clin Microbiol. 2011;49(1):345–53.
Sampath R, Mullholland N, Blyn LB, Massire C, Whitehouse CA, Waybright N, Harter C, Bogan J, Miranda MS, Smith D, Baldwin C, Wolcott M, Norwood D, Kreft R, Frinder M, Lovari R, Yasuda I, Matthews H, Toleno D, Housley R, Duncan D, Li F, Warren R, Eshoo MW, Hall TA, Hofstadler SA, Ecker DJ. Comprehensive biothreat cluster identification by PCR/electrospray-ionization mass pectrometry. PLoS One. 2012;7(6):e36528.
The views expressed herein are those of the authors and do not reflect the official views, policy or position of the Uniformed Services University of the Health Sciences, the Department of the Army, Department of the Air Force, Department of Defense, or the US Government. The authors are employees of the US government. This work was prepared as part of their official duties and, as such, there is no copyright to be transferred. Mention of trade names, commercial products, or organizations does not imply endorsement by the U.S. Government.
This work was supported by the Armed Forces Health Surveillance Center including the Global Emerging Infections Surveillance and Response System, and Allegheny Singer Research Institute of the Allegheny Health Network.
Availability of data and materials
The authors confirm that all data underlying the findings are fully available without restriction. Raw data underlying the conclusions of this paper are stored at the Infectious Disease Service, Brooke Army Medical Center and available upon request by contacting email@example.com.
Study design, Data Collection, Data Analysis, Manuscript Development, Writing Manuscript: RV, CKM, KM, KSA, GE, TJV; Data collection, Manuscript Development: RMK, JW, TS, CG, WZ, MLB, EAR; All authors read and approved the final manuscript.
The authors declare that they have no competing interests.
Consent for publication
Ethics approval and consent to participate
This study was conducted under a protocol approved by the Brooke Army Medical Center Institutional Review Board and in accordance with the approved protocol. All participants provided informed written consent at time of study enrollment.